Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MINERVA SURGICAL, INC.

(UTRS)
  Report
Delayed Nasdaq  -  04:00 2022-09-30 pm EDT
0.7954 USD   -2.96%
09/16August 2022 Federal Circuit Updates
AQ
08/29Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Conference
AQ
08/19Federal Circuit Revisits Assignor Estoppel
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (UTRS) MINERVA SURGICAL Posts Q2 Revenue $13M, vs. Street Est of $13.4M

08/09/2022 | 04:05pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MINERVA S.A. -2.11% 12.54 Delayed Quote.20.85%
MINERVA SURGICAL, INC. -2.96% 0.7954 Delayed Quote.-84.53%
All news about MINERVA SURGICAL, INC.
09/16August 2022 Federal Circuit Updates
AQ
08/29Minerva Surgical to Present at the H.C. Wainwright 24th Annual Global Investment Confer..
AQ
08/19Federal Circuit Revisits Assignor Estoppel
AQ
08/17Last Week In The Federal Circuit (au : Taking A Round Trip On The Assignor Estoppel Expres..
AQ
08/12Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling
MT
08/10JPMorgan Double Downgrades Minerva Surgical to Underweight From Overweight
MT
08/10Piper Sandler Adjusts Minerva Surgical's Price Target to $5 From $6, Reiterates Overwei..
MT
08/09Minerva Surgical : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)
PU
08/09MINERVA SURGICAL INC Management's Discussion and Analysis of Financial Condition and R..
AQ
08/09Minerva Surgical, Inc. Reports Earnings Results for the Second Quarter and Six Months E..
CI
More news
Analyst Recommendations on MINERVA SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2022 51,1 M - -
Net income 2022 -32,6 M - -
Net Debt 2022 12,1 M - -
P/E ratio 2022 -0,70x
Yield 2022 -
Capitalization 23,0 M 23,0 M -
EV / Sales 2022 0,69x
EV / Sales 2023 1,20x
Nbr of Employees 157
Free-Float 92,6%
Chart MINERVA SURGICAL, INC.
Duration : Period :
Minerva Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MINERVA SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 0,80 $
Average target price 5,00 $
Spread / Average Target 529%
EPS Revisions
Managers and Directors
David M. Clapper President, Chief Executive Officer & Director
Joel R. Jung Chief Financial Officer
Ross A. Jaffe Chairman
Eugene V. Skalnyi Vice President-Medical Affairs
Dominique J. Filloux Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MINERVA SURGICAL, INC.-84.53%23
STRYKER CORPORATION-24.26%76 625
SMITH & NEPHEW PLC-18.79%10 178
INSPIRE MEDICAL SYSTEMS, INC.-22.90%5 106
AXONICS, INC.25.79%3 460
GLAUKOS CORPORATION19.80%2 533